Search
Imunon Inc
IMNNAdd to Watchlist
1.820USD
-0.040-2.15%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
7.65MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Imunon Inc is 8.00, ranking 165 out of 389 in the Biotechnology & Medical Research industry. The average price target is 45.00, with a high of 182.61 and a low of 21.00.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
17.000
Target Price
+813.98%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Imunon Inc
IMNN
4
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Imunon Inc's price target?
Analysts forecast that Imunon Inc's price target is USD 45.00, with the highest forecast at USD 182.61 and the lowest forecast at USD 21.00.
How have Imunon IncIMNN's recent earnings per share performed?
The market expectation was USD -0.84, while Imunon IncIMNN's earnings per share (EPS) for the previous quarter was USD -2.02. EPS for the next quarter is expected at USD -0.93.
What is the analyst rating for Imunon Inc?
Based on the ratings of Imunon Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
